Home › Funds › C WorldWide Group Holding A/S › IOVA

C WorldWide Group Holding A/S position in IOVA

IOVANCE BIOTHERAPEUTICS INC · Health Care

C WorldWide Group Holding A/S reported holding 1,260,000 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 0.47% of its reported portfolio and ranking #35 among its reported holdings. C WorldWide Group Holding A/S has disclosed IOVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.26M sh
Reported value held$18.67M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How C WorldWide Group Holding A/S's IOVA position evolved

C WorldWide Group Holding A/S first disclosed a stake in IOVA in Q3 2023 at 1,360,000 shares (US$6.2M). The position peaked in Q3 2026 at 1,260,000 shares, worth US$18.7M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 1,260,000 shares valued at US$18.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.36M $6.19M New
Q4 2023 1.36M $11.06M Hold
Q1 2024 1.06M $15.71M Reduce
Q2 2024 1.26M $10.11M Add
Q3 2024 1.26M $11.83M Hold
Q4 2024 1.26M $9.32M Hold
Q1 2025 1.26M $4.20M Hold
Q2 2025 1.26M $2.17M Hold
Q3 2025 1.26M $2.73M Hold
Q4 2025 1.26M $3.44M Hold
Q1 2026 1.26M $4.42M Hold
Q2 2026 1.26M $5.24M Hold
Q3 2026 1.26M $18.67M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IOVA and 13F data

IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Rhenman & Partners Asset Management AB (US$37.1M), Orion Investment Co (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IOVA

All IOVA fund holders →

FAQ

How long has C WorldWide Group Holding A/S held IOVA?

C WorldWide Group Holding A/S has disclosed IOVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is C WorldWide Group Holding A/S's current position in IOVA?

As of Q3 2026, C WorldWide Group Holding A/S holds 1.26M shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $18.67M, representing 0.47% of its reported portfolio and ranking #35.

Has C WorldWide Group Holding A/S been buying or selling IOVA?

In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in IOVA. The position peaked in Q3 2026 at 1.26M shares.

Which other funds hold IOVA?

Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Rhenman & Partners Asset Management AB, Orion Investment Co, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.